On 5thof February 2020 Harry Sokol was our guest speaker, talking about ‘Gut Microbiota in IBD: from description to therapeutic target’. Harry Sokol works at the Gastroenterology Department of Saint Antoine Hospital in Paris. His lab aims at deciphering the mechanisms involved in the crosstalk of host and microbiota crosstalk in health and disease. Harry Sokol shared recent published and unpublished data on prospect of Fecal microbiota transplantation (FMT) in the treatment of Inflammatory Bowel Diseases.
We have started ‘Gut and Friends’ lunch time seminars more than five years ago with a small audience in a correspondingly small room. With today’s lecture by Mr. Sokol, we took the opportunity to move our seminar series to a larger auditorium.
Sokol, H., Landman, C., Seksik, P. et al. Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study. Microbiome 8, 12 (2020). https://doi.org/10.1186/s40168-020-0792-5
Lavelle A, Hoffmann TW, Pham HP, Langella P, Guédon E, Sokol H. Baseline microbiota composition modulates antibiotic-mediated effects on the gut microbiota and host. Microbiome. 2019 Aug 2;7(1):111. doi: 10.1186/s40168-019-0725-3.